(PharmaNewsWire.Com, May 01, 2017 ) According to the report published by Market Data Forecast named Middle-East and Africa Antiviral Drugs which estimates market to grow from $2.04 billion from 2016 to $2.61 billion by 2021 with a CAGR of 5.07% in the forecast period 2016-2021.
Antiviral drugs Market are a class of medical drugs used for fighting viral infection. From the past few years it has been observed that viruses have developed a resistance against anti-viral drugs. This calls for evolution of antiviral drugs that attacks certain viruses specifically at specified targets such as DNA polymerase, Reverse Transcriptase and NS3 Protease.
These drugs are injected to weaken the replication of viruses and strengthening the immune response to the viral infection. This drugs help in battling diseases like HIV/AIDS, Hepatitis, influenza and other viral infections.
Prevalence of life-threatening diseases, Increase in public awareness towards healthy lifestyle, increasing support for development of novel drugs and rise in healthcare expenditure are the factors responsible for growth in this market. Companies are collaborating with each other to invest in research and development to create new innovative products which add up to growth of the market. Also various kinds of antiviral drugs in the market provide huge opportunity for pharmaceutical companies to spread business in the region.
The Antiviral Drugs Market is based on different application, target and end-user. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Geographically Antiviral drugs market is segmented as Africa and Middle-East regions. World Health Organization stats showed 25.6 million people are living with HIV in Sub-Saharan Africa in 2015, making it one of the most affected regions, creating a lot of demand in Africa.
The major companies dominating the Antiviral Drugs Market are Johnson & Johnson, Novartis International AG, Roche Holding AG, Pfizer (USA), Merck and Co. Inc., and GlaxoSmithKline plc. AstraZeneca AB, Gilead Sciences, and Abbott Laboratories.
Scope of the Middle-East and Africa Antiviral Drugs Market:
Regional and country-level analysis that provides an innate perspective of Middle-East and African regional Markets.
To detect major focus areas of industrial growth Segment-level analysis on basis of type, products, application and end-user along with market size forecasts and y-o-y estimations are provided
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
PESTLE and Porters Five Forces Analyses that examine the macro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout other related studies in the Pharmaceuticals Segment:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
